Biotech news
Americas
Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review. 1 September 2015
Americas
The US Food and Drug Administration has proposed using four-letter suffixes to name biosimilar drugs. 1 September 2015
Pharma
The competence in various areas of the new Unified Patent Court is a matter of conjecture, as Paul England and Christof Höhne of law firm Taylor Wessing report. 27 August 2015
Americas
Law firm Dechert has hired Andrea Reid as partner to the firm’s intellectual property practice in Boston. 14 August 2015
Americas
Hedge fund manager Kyle Bass has fired a response to a motion filed by biotechnology company Celgene seeking to sanction him over “abusive” patent challenges, stating that profit motive is at the centre of every inter partes review filing. 13 August 2015
Pharma
The UK Intellectual Property Office has revealed the location for the country’s central and local divisions of the forthcoming Unified Patent Court. 12 August 2015
Americas
A US court has ruled that biotechnology company Regeneron engaged in “inequitable conduct” after finding that it withheld information from a patent application for a genetically modified mouse. 11 August 2015
Americas
The European Commission has approved US pharmaceutical company Pfizer’s $17 billion acquisition of Hospira, a move that will see Pfizer acquire the drugs company’s biosimilar portfolio. 6 August 2015
Americas
A Brazilian court has confirmed that a eucalyptus breed produced by biotechnology company Eldorado Brasil Celulose is genetically identical to pulp producer Fibria Celulose’s own cultivar product VTO2. 4 August 2015
Americas
The US Court of Appeals for the Federal Circuit’s decision in Amgen v Sandoz is what the biosimilar industry would have been hoping for but clarity is lacking in several areas, lawyers have told LSIPR. 23 July 2015